Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 7542693)

Published in J Med Virol on May 01, 1995

Authors

A Majid1, R Holmes, U Desselberger, P Simmonds, T A McKee

Author Affiliations

1: Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, United Kingdom.

Articles by these authors

(truncated to the top 100)

Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41

Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature (1978) 5.43

The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77

Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65

Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37

HCV confirmatory testing of blood donors. Lancet (1991) 3.29

Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27

Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25

Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. J Virol (1989) 3.19

Sequence diversity of small, round-structured viruses in the Norwalk virus group. J Virol (1994) 3.11

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10

Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91

Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68

Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45

Robotic radical prostatectomy in the community setting--the learning curve and beyond: initial 200 cases. J Urol (2005) 2.33

The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26

Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24

A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23

Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20

Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19

Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13

Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07

Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol (2001) 2.06

HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03

Generation of mucosal mast cells is stimulated in vitro by factors derived from T cells of helminth-infected rats. Nature (1982) 2.02

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00

Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98

No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96

The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94

Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93

A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area? Commun Dis Public Health (1998) 1.92

Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88

HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88

A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J Virol (1993) 1.86

Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86

Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses. J Virol Methods (1999) 1.81

Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73

Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol (1967) 1.71

Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68

Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell (1979) 1.68

Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68

Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68

Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J Clin Microbiol (1989) 1.67

Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol (1993) 1.66

HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain (1998) 1.65

Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65

Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England. Epidemiol Infect (1993) 1.65

Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol (2000) 1.63

Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer (2001) 1.62

Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol (2004) 1.62

HIV-1 tropism and co-receptor use. Nature (1997) 1.60

Molecular weights of RNA segments of influenza A and B viruses. Virology (1978) 1.58

Molecular epidemiology of outbreaks of gastroenteritis associated with small round-structured viruses in East Anglia, United Kingdom, during the 1996-1997 season. J Clin Microbiol (1999) 1.57

NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res (1998) 1.57

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56

First coitus before menarche and risk of sexually transmitted disease. Lancet (1990) 1.55

Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol (1997) 1.55

Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis (1993) 1.54

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol (2010) 1.54

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53

Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med (1994) 1.51

Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis (2009) 1.50

Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in England. J Med Virol (1989) 1.50

In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50

Noncumulative sequence changes in the hemagglutinin genes of influenza C virus isolates. Virology (1985) 1.48

Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant (1997) 1.47

The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill (2010) 1.46

Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2015). Arch Virol (2015) 1.45

Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke (2000) 1.44

Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol (2001) 1.44

Screening respiratory samples for detection of human rhinoviruses (HRVs) and enteroviruses: comprehensive VP4-VP2 typing reveals high incidence and genetic diversity of HRV species C. J Clin Microbiol (2009) 1.44

The product of varicella-zoster virus gene 62 autoregulates its own promoter. J Gen Virol (1990) 1.43

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol (1997) 1.43

Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol (1998) 1.42

Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol (1998) 1.41

Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol (1996) 1.41

HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet (1988) 1.41

The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40

Infantile viral gastroenteritis: on the way to closing the diagnostic gap. J Med Virol (2003) 1.39

A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood (1985) 1.39

Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol (2009) 1.39

The genomes of rotaviruses isolated from chronically infected immunodeficient children. J Gen Virol (1984) 1.38

Genome rearrangements of bovine rotavirus after serial passage at high multiplicity of infection. Virology (1985) 1.37

Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting gram-negative bacteria and its use in molecular epidemiology. Antimicrob Agents Chemother (2001) 1.35

Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998. J Clin Microbiol (2000) 1.33

Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol (1994) 1.33

Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol (1997) 1.32

Human parechoviruses: biology, epidemiology and clinical significance. J Clin Virol (2009) 1.30

TT virus--part of the normal human flora? J Infect Dis (1999) 1.29